Opinion|Articles|December 15, 2023
Supplements and Featured Publications
- Treatment of Spinal Muscular Atrophy: Managed Care Considerations for Gene Therapy
Treatment of Spinal Muscular Atrophy: Managed Care Considerations for Gene Therapy
Advertisement
This AJMC® Clinical Brief focuses on managed care considerations for the treatment of spinal muscular atrophy.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
